Abstract
Thirteen patients affected by endometriosis have been treated with GnRH analogue Buserelin. CA-125 serum levels have been monitored before, during and after treatment. Analysis of data suggests the hypothesis of an individualized follow up by means of repeated assays of CA-125 and their reference to pre and post treatment graphs.
MeSH terms
-
Adult
-
Analysis of Variance
-
Antigens, Tumor-Associated, Carbohydrate / blood*
-
Buserelin / adverse effects
-
Buserelin / therapeutic use*
-
Endometriosis / blood
-
Endometriosis / diagnosis*
-
Endometriosis / drug therapy
-
Estradiol / blood
-
Female
-
Follicle Stimulating Hormone / blood
-
Follow-Up Studies
-
Humans
-
Luteinizing Hormone / blood
-
Menstrual Cycle / metabolism
-
Pelvic Neoplasms / diagnosis*
-
Pelvic Neoplasms / drug therapy
-
Pelvic Neoplasms / immunology
-
Progesterone / blood
Substances
-
Antigens, Tumor-Associated, Carbohydrate
-
Progesterone
-
Estradiol
-
Luteinizing Hormone
-
Follicle Stimulating Hormone
-
Buserelin